Anti-SLC9A3R1 antibody produced in rabbit

SLC9A3R1 (solute carrier 9A3 receptor 1), commonly known as Na⁺/H⁺ exchanger regulatory factor 1 (NHERF1), is an ezrin-radixin-moesin (ERM)-binding phosphoprotein 50. This gene is localized to human chromosome 17q25.1, and codes for a scaffold protein. This protein consists of two tandem PDZ domains and a C-terminal ezrin-binding region.

Ezrin-radixin-moesin-binding phosphoprotein 50 recombinant protein epitope signature tag (PrEST)

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

SLC9A3R1 (solute carrier 9A3 receptor 1) protein plays an essential role in the binding of integral membrane proteins to cytoskeleton. Thus, it is thought to be a key player in cell signaling involved in cytoskeleton dynamics. Its expression is linked with multiple types of cancer and their aggressiveness. In breast cancer, its loss of nuclear expression is linked with decreased survival. Studies in colon adenocarcinoma HT-29 epithelial cells show that this protein plays an essential role in cellular proliferation through Gq-mediated signalling pathways. It also controls EGF (epidermal growth factor) and neurotensin signaling in HT-29 cell line. It plays an essential role in the biogenesis of microvilli, where it is critical for the retention of specific proteins in the microvilli. Activation by Rac1 protein results in conformation changes in SLC9A3R1 protein, which leads to the anchoring of cystic fibrosis transmembrane conductance regulator (CFTR) in the cell membrane.

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Corresponding Antigen APREST70135

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.